The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infection Prevention and Enteral Access Market Research Report 2025
Synopsis
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
The global Infection Prevention and Enteral Access market was valued at US$ 1512.3 million in 2023 and is anticipated to reach US$ 2483 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
This report aims to provide a comprehensive presentation of the global market for Infection Prevention and Enteral Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infection Prevention and Enteral Access.
Report Scope
The Infection Prevention and Enteral Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infection Prevention and Enteral Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infection Prevention and Enteral Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
Segment by Type
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Segment by Application
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infection Prevention and Enteral Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Enteral access is the process by which nutrition is delivered to the patient. It is usually used in hospitalized patients; in this process, liquid supplements or daily requirements are fed to the patient with the help of a tube.
The global Infection Prevention and Enteral Access market was valued at US$ 1512.3 million in 2023 and is anticipated to reach US$ 2483 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Factors such as presence of postoperative patients with limited oral intake, increasing incidences of severe pancreatitis and chronic diseases, increasing geriatric population, technological advancements, and higher immature births drive the market growth.
Moreover, increasing RandD investments and untapped market opportunities in developing countries increase opportunities for the market growth.
This report aims to provide a comprehensive presentation of the global market for Infection Prevention and Enteral Access, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infection Prevention and Enteral Access.
Report Scope
The Infection Prevention and Enteral Access market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infection Prevention and Enteral Access market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infection Prevention and Enteral Access companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
Segment by Type
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes
Segment by Application
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infection Prevention and Enteral Access companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enteral Feeding Pumps
1.2.3 Enteral Feeding Tubes
1.2.4 Administration Reservoirs
1.2.5 Giving Sets
1.2.6 Enteral Syringes
1.3 Market by Application
1.3.1 Global Infection Prevention and Enteral Access Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Gastroenterology
1.3.4 Diabetes
1.3.5 Neurological Disorders
1.3.6 Hypermetabolism
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infection Prevention and Enteral Access Market Perspective (2019-2030)
2.2 Infection Prevention and Enteral Access Growth Trends by Region
2.2.1 Global Infection Prevention and Enteral Access Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infection Prevention and Enteral Access Historic Market Size by Region (2019-2024)
2.2.3 Infection Prevention and Enteral Access Forecasted Market Size by Region (2025-2030)
2.3 Infection Prevention and Enteral Access Market Dynamics
2.3.1 Infection Prevention and Enteral Access Industry Trends
2.3.2 Infection Prevention and Enteral Access Market Drivers
2.3.3 Infection Prevention and Enteral Access Market Challenges
2.3.4 Infection Prevention and Enteral Access Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infection Prevention and Enteral Access Players by Revenue
3.1.1 Global Top Infection Prevention and Enteral Access Players by Revenue (2019-2024)
3.1.2 Global Infection Prevention and Enteral Access Revenue Market Share by Players (2019-2024)
3.2 Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infection Prevention and Enteral Access Revenue
3.4 Global Infection Prevention and Enteral Access Market Concentration Ratio
3.4.1 Global Infection Prevention and Enteral Access Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infection Prevention and Enteral Access Revenue in 2023
3.5 Infection Prevention and Enteral Access Key Players Head office and Area Served
3.6 Key Players Infection Prevention and Enteral Access Product Solution and Service
3.7 Date of Enter into Infection Prevention and Enteral Access Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infection Prevention and Enteral Access Breakdown Data by Type
4.1 Global Infection Prevention and Enteral Access Historic Market Size by Type (2019-2024)
4.2 Global Infection Prevention and Enteral Access Forecasted Market Size by Type (2025-2030)
5 Infection Prevention and Enteral Access Breakdown Data by Application
5.1 Global Infection Prevention and Enteral Access Historic Market Size by Application (2019-2024)
5.2 Global Infection Prevention and Enteral Access Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infection Prevention and Enteral Access Market Size (2019-2030)
6.2 North America Infection Prevention and Enteral Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infection Prevention and Enteral Access Market Size by Country (2019-2024)
6.4 North America Infection Prevention and Enteral Access Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infection Prevention and Enteral Access Market Size (2019-2030)
7.2 Europe Infection Prevention and Enteral Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infection Prevention and Enteral Access Market Size by Country (2019-2024)
7.4 Europe Infection Prevention and Enteral Access Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infection Prevention and Enteral Access Market Size (2019-2030)
8.2 Asia-Pacific Infection Prevention and Enteral Access Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infection Prevention and Enteral Access Market Size by Region (2019-2024)
8.4 Asia-Pacific Infection Prevention and Enteral Access Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infection Prevention and Enteral Access Market Size (2019-2030)
9.2 Latin America Infection Prevention and Enteral Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infection Prevention and Enteral Access Market Size by Country (2019-2024)
9.4 Latin America Infection Prevention and Enteral Access Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infection Prevention and Enteral Access Market Size (2019-2030)
10.2 Middle East & Africa Infection Prevention and Enteral Access Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infection Prevention and Enteral Access Market Size by Country (2019-2024)
10.4 Middle East & Africa Infection Prevention and Enteral Access Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cook Medical
11.1.1 Cook Medical Company Detail
11.1.2 Cook Medical Business Overview
11.1.3 Cook Medical Infection Prevention and Enteral Access Introduction
11.1.4 Cook Medical Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.1.5 Cook Medical Recent Development
11.2 Medtronic Plc
11.2.1 Medtronic Plc Company Detail
11.2.2 Medtronic Plc Business Overview
11.2.3 Medtronic Plc Infection Prevention and Enteral Access Introduction
11.2.4 Medtronic Plc Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.2.5 Medtronic Plc Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Introduction
11.3.4 Boston Scientific Corporation Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.3.5 Boston Scientific Corporation Recent Development
11.4 CONMED Corporation
11.4.1 CONMED Corporation Company Detail
11.4.2 CONMED Corporation Business Overview
11.4.3 CONMED Corporation Infection Prevention and Enteral Access Introduction
11.4.4 CONMED Corporation Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.4.5 CONMED Corporation Recent Development
11.5 CORPAK MedSystems
11.5.1 CORPAK MedSystems Company Detail
11.5.2 CORPAK MedSystems Business Overview
11.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Introduction
11.5.4 CORPAK MedSystems Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.5.5 CORPAK MedSystems Recent Development
11.6 CR Bard
11.6.1 CR Bard Company Detail
11.6.2 CR Bard Business Overview
11.6.3 CR Bard Infection Prevention and Enteral Access Introduction
11.6.4 CR Bard Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.6.5 CR Bard Recent Development
11.7 ALCOR Scientific
11.7.1 ALCOR Scientific Company Detail
11.7.2 ALCOR Scientific Business Overview
11.7.3 ALCOR Scientific Infection Prevention and Enteral Access Introduction
11.7.4 ALCOR Scientific Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.7.5 ALCOR Scientific Recent Development
11.8 Pacific Hospital Supply
11.8.1 Pacific Hospital Supply Company Detail
11.8.2 Pacific Hospital Supply Business Overview
11.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Introduction
11.8.4 Pacific Hospital Supply Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.8.5 Pacific Hospital Supply Recent Development
11.9 Teleflexorporated
11.9.1 Teleflexorporated Company Detail
11.9.2 Teleflexorporated Business Overview
11.9.3 Teleflexorporated Infection Prevention and Enteral Access Introduction
11.9.4 Teleflexorporated Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.9.5 Teleflexorporated Recent Development
11.10 Vygon SA
11.10.1 Vygon SA Company Detail
11.10.2 Vygon SA Business Overview
11.10.3 Vygon SA Infection Prevention and Enteral Access Introduction
11.10.4 Vygon SA Revenue in Infection Prevention and Enteral Access Business (2019-2024)
11.10.5 Vygon SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infection Prevention and Enteral Access Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enteral Feeding Pumps
Table 3. Key Players of Enteral Feeding Tubes
Table 4. Key Players of Administration Reservoirs
Table 5. Key Players of Giving Sets
Table 6. Key Players of Enteral Syringes
Table 7. Global Infection Prevention and Enteral Access Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Infection Prevention and Enteral Access Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Infection Prevention and Enteral Access Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Infection Prevention and Enteral Access Market Share by Region (2019-2024)
Table 11. Global Infection Prevention and Enteral Access Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Infection Prevention and Enteral Access Market Share by Region (2025-2030)
Table 13. Infection Prevention and Enteral Access Market Trends
Table 14. Infection Prevention and Enteral Access Market Drivers
Table 15. Infection Prevention and Enteral Access Market Challenges
Table 16. Infection Prevention and Enteral Access Market Restraints
Table 17. Global Infection Prevention and Enteral Access Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Infection Prevention and Enteral Access Market Share by Players (2019-2024)
Table 19. Global Top Infection Prevention and Enteral Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Prevention and Enteral Access as of 2023)
Table 20. Ranking of Global Top Infection Prevention and Enteral Access Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Infection Prevention and Enteral Access Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infection Prevention and Enteral Access Product Solution and Service
Table 24. Date of Enter into Infection Prevention and Enteral Access Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infection Prevention and Enteral Access Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Infection Prevention and Enteral Access Revenue Market Share by Type (2019-2024)
Table 28. Global Infection Prevention and Enteral Access Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Infection Prevention and Enteral Access Revenue Market Share by Type (2025-2030)
Table 30. Global Infection Prevention and Enteral Access Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Infection Prevention and Enteral Access Revenue Market Share by Application (2019-2024)
Table 32. Global Infection Prevention and Enteral Access Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Infection Prevention and Enteral Access Revenue Market Share by Application (2025-2030)
Table 34. North America Infection Prevention and Enteral Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Infection Prevention and Enteral Access Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Infection Prevention and Enteral Access Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Infection Prevention and Enteral Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Infection Prevention and Enteral Access Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Infection Prevention and Enteral Access Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Infection Prevention and Enteral Access Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Infection Prevention and Enteral Access Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Infection Prevention and Enteral Access Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Infection Prevention and Enteral Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Infection Prevention and Enteral Access Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Infection Prevention and Enteral Access Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Infection Prevention and Enteral Access Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Infection Prevention and Enteral Access Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Infection Prevention and Enteral Access Market Size by Country (2025-2030) & (US$ Million)
Table 49. Cook Medical Company Detail
Table 50. Cook Medical Business Overview
Table 51. Cook Medical Infection Prevention and Enteral Access Product
Table 52. Cook Medical Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 53. Cook Medical Recent Development
Table 54. Medtronic Plc Company Detail
Table 55. Medtronic Plc Business Overview
Table 56. Medtronic Plc Infection Prevention and Enteral Access Product
Table 57. Medtronic Plc Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 58. Medtronic Plc Recent Development
Table 59. Boston Scientific Corporation Company Detail
Table 60. Boston Scientific Corporation Business Overview
Table 61. Boston Scientific Corporation Infection Prevention and Enteral Access Product
Table 62. Boston Scientific Corporation Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 63. Boston Scientific Corporation Recent Development
Table 64. CONMED Corporation Company Detail
Table 65. CONMED Corporation Business Overview
Table 66. CONMED Corporation Infection Prevention and Enteral Access Product
Table 67. CONMED Corporation Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 68. CONMED Corporation Recent Development
Table 69. CORPAK MedSystems Company Detail
Table 70. CORPAK MedSystems Business Overview
Table 71. CORPAK MedSystems Infection Prevention and Enteral Access Product
Table 72. CORPAK MedSystems Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 73. CORPAK MedSystems Recent Development
Table 74. CR Bard Company Detail
Table 75. CR Bard Business Overview
Table 76. CR Bard Infection Prevention and Enteral Access Product
Table 77. CR Bard Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 78. CR Bard Recent Development
Table 79. ALCOR Scientific Company Detail
Table 80. ALCOR Scientific Business Overview
Table 81. ALCOR Scientific Infection Prevention and Enteral Access Product
Table 82. ALCOR Scientific Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 83. ALCOR Scientific Recent Development
Table 84. Pacific Hospital Supply Company Detail
Table 85. Pacific Hospital Supply Business Overview
Table 86. Pacific Hospital Supply Infection Prevention and Enteral Access Product
Table 87. Pacific Hospital Supply Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 88. Pacific Hospital Supply Recent Development
Table 89. Teleflexorporated Company Detail
Table 90. Teleflexorporated Business Overview
Table 91. Teleflexorporated Infection Prevention and Enteral Access Product
Table 92. Teleflexorporated Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 93. Teleflexorporated Recent Development
Table 94. Vygon SA Company Detail
Table 95. Vygon SA Business Overview
Table 96. Vygon SA Infection Prevention and Enteral Access Product
Table 97. Vygon SA Revenue in Infection Prevention and Enteral Access Business (2019-2024) & (US$ Million)
Table 98. Vygon SA Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infection Prevention and Enteral Access Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infection Prevention and Enteral Access Market Share by Type: 2023 VS 2030
Figure 3. Enteral Feeding Pumps Features
Figure 4. Enteral Feeding Tubes Features
Figure 5. Administration Reservoirs Features
Figure 6. Giving Sets Features
Figure 7. Enteral Syringes Features
Figure 8. Global Infection Prevention and Enteral Access Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Infection Prevention and Enteral Access Market Share by Application: 2023 VS 2030
Figure 10. Oncology Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Diabetes Case Studies
Figure 13. Neurological Disorders Case Studies
Figure 14. Hypermetabolism Case Studies
Figure 15. Others Case Studies
Figure 16. Infection Prevention and Enteral Access Report Years Considered
Figure 17. Global Infection Prevention and Enteral Access Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Infection Prevention and Enteral Access Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Infection Prevention and Enteral Access Market Share by Region: 2023 VS 2030
Figure 20. Global Infection Prevention and Enteral Access Market Share by Players in 2023
Figure 21. Global Top Infection Prevention and Enteral Access Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infection Prevention and Enteral Access as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Infection Prevention and Enteral Access Revenue in 2023
Figure 23. North America Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Infection Prevention and Enteral Access Market Share by Country (2019-2030)
Figure 25. United States Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Infection Prevention and Enteral Access Market Share by Country (2019-2030)
Figure 29. Germany Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Infection Prevention and Enteral Access Market Share by Region (2019-2030)
Figure 37. China Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Infection Prevention and Enteral Access Market Share by Country (2019-2030)
Figure 45. Mexico Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Infection Prevention and Enteral Access Market Share by Country (2019-2030)
Figure 49. Turkey Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Infection Prevention and Enteral Access Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Cook Medical Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 52. Medtronic Plc Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 53. Boston Scientific Corporation Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 54. CONMED Corporation Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 55. CORPAK MedSystems Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 56. CR Bard Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 57. ALCOR Scientific Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 58. Pacific Hospital Supply Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 59. Teleflexorporated Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 60. Vygon SA Revenue Growth Rate in Infection Prevention and Enteral Access Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
